Income from Continuous Operations: A company's total income or loss before discontinued operations, extraordinary items, preferred stock dividends and accounting change.
Corcept Therapeutics Incorporated (CORT) had Income from Continuous Operations of $24.29M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$202.12M |
|
$23.91M |
|
$2.54M |
|
$199.58M |
|
$197.64M |
|
$4.49M |
|
$5.42M |
|
$9.91M |
|
$9.91M |
|
$24.29M |
|
|
Income from Continuous Operations |
$24.29M |
$24.29M |
|
$24.29M |
|
$4.49M |
|
$-0.13M |
|
103.86M |
|
119.99M |
|
$0.24 |
|
$0.20 |
|
| Balance Sheet Financials | |
$485.46M |
|
$1.89M |
|
$351.19M |
|
$836.65M |
|
$166.09M |
|
$5.02M |
|
$22.76M |
|
$188.85M |
|
$647.80M |
|
$647.80M |
|
$647.80M |
|
105.97M |
|
| Cash Flow Statement Financials | |
$142.00M |
|
$69.76M |
|
$-220.37M |
|
$127.67M |
|
$120.50M |
|
$-7.17M |
|
$84.50M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.92 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
98.74% |
|
2.22% |
|
2.22% |
|
-- |
|
4.90% |
|
11.83% |
|
$141.78M |
|
-- |
|
-- |
|
-- |
|
0.24 |
|
0.20 |
|
3.38 |
|
26.62 |
|
3.75% |
|
3.75% |
|
2.90% |
|
3.72% |
|
$6.11 |
|
$1.18 |
|
$1.18 |
|